Can Glucarpidase Help Reverse Methotrexate Kidney Damage?January 9, 2025Mixed TopicsB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaALLAggressive LymphomasAML
FL: Tafasitamab Plus Combo Boosts OutcomesDecember 18, 2024Non-Hodgkin LymphomaIndolent LymphomaB Cell LymphomaDLBCL
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Patient & Survivor CareMixed TopicsDLBCLBusiness of MedicineAggressive LymphomasAMLALL
Does Acalabrutinib Fit Into Frontline MCL Therapy?December 11, 2024Mantle Cell LymphomaB Cell LymphomaASH 2024
Epcore NHL-1 Update: Treatment Effective Before CAR TDecember 10, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaCellular TherapyASH 2024
LBCL: Bispecific Antibodies Fare Less Well in Real-World AnalysisDecember 9, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaPatient & Survivor CareASH 2024
Inside the Patient-Oncologist Bond: Why It’s Often So StrongDecember 2, 2024Patient & Survivor CareMixed TopicsDLBCLMultiple MyelomaAMLAggressive LymphomasALL
Outpatient CAR T: Safe, Effective, AccessibleNovember 4, 2024Cellular TherapyB Cell LymphomaMantle Cell LymphomaMultiple MyelomaMixed TopicsBusiness of MedicinePatient & Survivor Care
For Radiation ‘Downwinders,’ Cancer Compensation Is On HoldOctober 25, 2024Patient & Survivor CareNon-Hodgkin LymphomaMultiple MyelomaDLBCLCMLALLAML
Popular Weight Loss Drugs Now for Patients With Cancer?September 30, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Dr. Rogers’ Neighborhood: Guinea Pigs and Groundbreaking Cancer CareSeptember 27, 2024CLLB Cell LymphomaPatient & Survivor Care
Does Medicare Advantage Offer Higher-Value Chemotherapy?September 26, 2024Patient & Survivor CareMixed TopicsBusiness of MedicineALLAggressive LymphomasAMLB Cell Lymphoma
AACR Cancer Progress Report: Big Strides and Big GapsSeptember 26, 2024Patient & Survivor CareDiversity in MedicineDLBCLMixed TopicsPediatricsAggressive LymphomasALL
Cancer Risk: Are Pesticides the New Smoking?September 20, 2024Patient & Survivor CareALLAMLAggressive LymphomasB Cell LymphomaBusiness of MedicineCLL
To Choose the Best First-line Drug for CML, Consider Efficacy and CostSeptember 6, 2024CMLCLLBusiness of MedicinePatient & Survivor CareB Cell Lymphoma
